Adis Journals
Browse
Summary slide.png (114.6 kB)

Effects if the Once-Weekly DPP-4 Inhibitor Omarigliptin on Glycemic Control in Patients with Type 2 Diabetes Mellitus on Maintenance Hemodialysis: A 24-Week Open-Label, Multicenter Randomized Controlled Study

Download (114.6 kB)
media
posted on 2021-01-12, 10:23 authored by Yuta Yoshizawa, Michihiro Hosojima, Hideyuki Kabasawa, Naohito Tanabe, Daisuke Ugamura, Yutaka Koda, Hisaki Shimada, Tetsuya Takasawa, Takahito Ito, Tadahiro Kitamura, Masaki Kobayashi, Yoshiki Suzuki, Ichiei Narita, Akihiko Saito

Article full text


The above summary slide represents the opinions of the authors. For a full list of declarations, including funding and author disclosure statements, please see the full text online (see “read the peer-reviewed publication” opposite).

© The authors, CC-BY-NC 2021.

History

Usage metrics

    Diabetes Therapy

    Categories

    Keywords

    LinagliptinHemodialysisOnce-weekly dipeptidase-4 inhibitorOmarigliptinType 2 diabetes mellitus

    Licence

    CC BY-NC 4.0

    Exports